https://doi.org/10.4081/monaldi.2021.2065
Loss of engagement in controlling chronic anticoagulation therapy during Covid-19 stringency measures. A single center experience of disproportioned increase of stuck mechanical valves
Submitted: August 25, 2021
Accepted: September 22, 2021
Published: December 3, 2021
Accepted: September 22, 2021
Abstract Views: 1018
PDF: 456
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Stuck valve is a very rare and severe complication that occurs in mechanical valve replacement patients with ineffective anticoagulation. However, with COVID-19 restriction measures, it became challenging to regularly assess INR to make sure it falls within the target therapeutic range to prevent this complication. We present a series of 10 patients who either underwent transthoracic echocardiography for a suspected stuck valve or were seen at the outpatient valve clinic with the residual consequences of a stuck valve during the COVID-19 restriction measures in our institute. Stuck prosthetic valves incident has increased significantly during this period, particularly those in the mitral position for which urgent replacement and prolonged hospitalization were necessary. Particularly with the COVID-19 restrictions in place, these cases highlight the need for physicians to be aware of the dramatic increase in the incidence of stuck prosthetic valves in patients on chronic warfarin therapy.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239.
DOI: https://doi.org/10.1001/jama.2020.2648
Veldtman GR, Pirisi M, et al. Management principles in patients with COVID-19: perspectives from a growing global experience with emphasis on cardiovascular surveillance. Open Heart 2020;7:e001357.
DOI: https://doi.org/10.1136/openhrt-2020-001357
Nash DB, Angelo M, Nash EJ, et al. We know health is not elective: Impacts of COVID-19. Popul Health Manag 2020;23:378-85.
DOI: https://doi.org/10.1089/pop.2020.0161
Hübner M, Zingg T, Martin D, et al. Surgery for non-Covid-19 patients during the pandemic. PLoS One 2020;15:e0241331.
DOI: https://doi.org/10.1371/journal.pone.0241331
Jazieh AR, Akbulut H, Curigliano G, et al. Impact of the COVID-19 pandemic on cancer care: A global collaborative study. JCO Glob Oncol 2020;6:1428-38.
DOI: https://doi.org/10.1200/GO.20.00351
Rosenbaum L. The untold toll — The Pandemic’s effects on patients without Covid-19. N Engl J Med 2020;382:2368–71.
DOI: https://doi.org/10.1056/NEJMms2009984
Shah BN, Schlosshan D, McConkey HZR, et al. Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care. Heart 2020;106:1549–54.
DOI: https://doi.org/10.1136/heartjnl-2020-317600
Ryffel C, Lanz J, Corpataux N, et al. Mortality, stroke, and hospitalization associated with deferred vs expedited aortic valve replacement in patients referred for symptomatic severe aortic stenosis during the COVID-19 pandemic. JAMA Netw Open 2020;3:e2020402.
DOI: https://doi.org/10.1001/jamanetworkopen.2020.20402
Ejiofor JI, Hirji SA, Val FR-D, et al. Outcomes of repeat mitral valve replacement in patients with prior mitral surgery: A benchmark for transcatheter approaches. J Thorac Cardiovasc Surg 2018;156:619-627.e1.
DOI: https://doi.org/10.1016/j.jtcvs.2018.03.126
Deviri E, Sareli P, Wisenbaugh T, Cronje SL. Obstruction of mechanical heart valve prostheses: Clinical aspects and surgical management. J Am Coll Cardiol 1991;17:646-50.
DOI: https://doi.org/10.1016/S0735-1097(10)80178-0
Azpitarte J, Sánchez-Ramos J, Oyonarte JM, et al. [Trombosis valvular protésica: ¿cuál es la terapia inicial más apropiada?].[Article in Spanish]. Rev Esp Cardiol2001;54:1367-76.
DOI: https://doi.org/10.1016/S0300-8932(01)76519-0
Mansfield KE, Mathur R, Tazare J, et al. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study. Lancet Digit Health 2021;3:e217–30.
DOI: https://doi.org/10.1016/S2589-7500(21)00017-0
Samargandy S, Al Garni TA, Almoghairi A, et al. Effect of COVID-19 pandemic on the cardiac outpatients’ perception of seeking medical advice. J Saudi Heart Assoc 2020;32:377–82.
DOI: https://doi.org/10.37616/2212-5043.1094
Kheirkhah P, Feng Q, Travis LM, et al. Prevalence, predictors and economic consequences of no-shows. BMC Health Serv Res 2016;16:13.
DOI: https://doi.org/10.1186/s12913-015-1243-z
Shaw LJ, Pepine CJ, Xie J, et al. Quality and equitable health care gaps for women. J Am Coll Cardiol 2017;70:373-88.
DOI: https://doi.org/10.1016/j.jacc.2017.05.051
OECD [Internet]. Women at the core of the fight against COVID-19 crisis. Available from: https://www.oecd.org/coronavirus/policy-responses/women-at-the-core-of-the-fight-against-covid-19-crisis-553a8269/
How to Cite
Vriz, Olga, Andrea Rossi Zadra, Abdalla Eltayeb, Fatima Asiri, Claudio Pragliola, Nader Fawzy, Domenico Galzerano, et al. 2021. “Loss of Engagement in Controlling Chronic Anticoagulation Therapy During Covid-19 Stringency Measures. A Single Center Experience of Disproportioned Increase of Stuck Mechanical Valves”. Monaldi Archives for Chest Disease 92 (2). https://doi.org/10.4081/monaldi.2021.2065.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Andrea Palomba, Francesco Pelizzo, Mattia Canevari, Olga Vriz, Pulmonary edema in a young male with severe uncontrolled cardiovascular risk factors and pan-vascular atherosclerosis: a case report , Monaldi Archives for Chest Disease: Early Access
- Ana Filipa Amador, Catarina Martins da Costa, João da Silva Santos, Cláudia Camila Dias, Elisabete Martins, First-degree atrioventricular block in hypertrophic cardiomyopathy patients: an easy and worthy prognostic marker? , Monaldi Archives for Chest Disease: Early Access
- Karin Del Vecchio, Caterina Rizzardi, Alice Pozza, Francesco Prati, Luisa Ye, Alessia Fattoretto, Elena Reffo, Giovanni Di Salvo, How effective is disopyramide in treating pediatric hypertrophic cardiomyopathy? State of the art and future directions , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
- Richa Tyagi, Surya Kant, Sanjeev Kumar Verma, Ram Awadh Singh Kushwaha, Santosh Kumar, Rajiv Garg, Ajay Kumar Verma, Anand Srivastava, Darshan Kumar Bajaj, Anupam Wakhlu, Anit Parihar, Akshyaya Pradhan, Riddhi Jaiswal, Spectrum of interstitial lung diseases and their association with pulmonary hypertension , Monaldi Archives for Chest Disease: Vol. 92 No. 3 (2022)
- Naela Ashraf, Suha Zubairi, Mehnaz Atiq, Farheen Ahmed, Muneer Amanullah, Anomalous left coronary artery from pulmonary artery (ALCAPA) as a silent cause of mitral regurgitation in children , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
- Sabino Scardi, Paolo Umari, Bianca Maria D’Agata, Lower is better: ENHANCE affair , Monaldi Archives for Chest Disease: Vol. 70 No. 2 (2008): Cardiac series
- R.W. Dal Negro, R. Aquilani, S. Bertacco, F. Boschi, C. Micheletto, S. Tognella, Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia , Monaldi Archives for Chest Disease: Vol. 73 No. 1 (2010): Pulmonary series
- B. Singh, S. Arora, V. Khanna, Association of severity of COPD with IgE and interleukin-1beta , Monaldi Archives for Chest Disease: Vol. 73 No. 2 (2010): Pulmonary series
- G. Valli, P. Paoletti, D. Savi, D. Martolini, P. Palange, Clinical use of Heliox in Asthma and COPD , Monaldi Archives for Chest Disease: Vol. 67 No. 3 (2007): Pulmonary series
- O. Toungoussova, M.P. Foschino Barbaro, L.M. Esposito, G.E. Carpagnano, F.G. Salerno, R.W. Dal Negro, A. Spanevello, Brittle asthma , Monaldi Archives for Chest Disease: Vol. 67 No. 2 (2007): Pulmonary series
<< < 28 29 30 31 32 33 34 35 36 37 > >>
You may also start an advanced similarity search for this article.
